Erasca, Inc. (ERAS)
NASDAQ: ERAS · IEX Real-Time Price · USD
2.040
+0.040 (2.00%)
At close: Jun 18, 2024, 4:00 PM
1.940
-0.100 (-4.90%)
After-hours: Jun 18, 2024, 5:17 PM EDT

Erasca Market Cap

Erasca has a market cap or net worth of $530.08 million as of June 18, 2024. Its market cap has increased by 19.20% in one year.

Market Cap
530.08M
Enterprise Value
283.03M
1-Year Change
19.20%
Ranking
Category
Stock Price
$2.04

Market Cap Chart

Since the IPO on July 16, 2021, Erasca's market cap has decreased from $1.86B to $530.08M, a decrease of -71.47%. That is a compound annual growth rate of -34.89%.

History

DateMarket Cap% Change
Jun 17, 2024346.70M-7.84%
Jun 14, 2024376.20M-0.45%
Jun 13, 2024377.90M-1.82%
Jun 12, 2024384.90M-1.33%
Jun 11, 2024390.10M-1.32%
Jun 10, 2024395.30M-3.98%
Jun 7, 2024411.70M0.83%
Jun 6, 2024408.30M-10.11%
Jun 5, 2024454.20M0.38%
Jun 4, 2024452.50M1.16%
Jun 3, 2024447.30M2.38%
May 31, 2024436.90M1.63%
May 30, 2024429.90M2.90%
May 29, 2024417.80M-4.37%
May 28, 2024436.90M-4.17%
May 24, 2024455.90M1.54%
May 23, 2024449.00M6.15%
May 22, 2024423.00M3.83%
May 21, 2024407.40M4.92%
May 20, 2024388.30M13.70%
May 17, 2024341.50M6.49%
May 16, 2024320.70M-2.11%
May 15, 2024327.60M1.61%
May 14, 2024322.40M-2.13%
May 13, 2024329.40M2.71%
View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
iTeos Therapeutics 586.27M
Pharming Group 579.16M
Applied Therapeutics 577.05M
Lexeo Therapeutics 572.59M
Fulgent Genetics 571.25M
Savara 563.81M
PepGen 559.20M
Neurogene 552.83M
Market Cap Rankings